Metformin as a Novel Therapy for Autosomal Dominant Polycystic Kidney Disease

NCT02656017 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

97

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Kidney, Autosomal Dominant

Interventions

DRUG: Metformin
OTHER: Placebo

Sponsor

Kyongtae Ty Bae, M.D., Ph.D.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]